-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABP-745 in Gouty Arthritis (Gout)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABP-745 in Gouty Arthritis (Gout) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABP-745 in Gouty Arthritis (Gout) Drug Details: ABP-745 is under development...
-
Product Insights
Centrale Solaire ABP 26 Solar PV Park
Centrale Solaire ABP 26 Solar PV Park is a solar PV project located in Ile-de-France, France. The project is owned and being developed by Centrale Solaire TQ1 SASAU. The project is at the permitting stage. Empower your strategies with our Centrale Solaire ABP 26 Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Company Insights
Innovation and Patenting activity of Nordea Bank Abp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Nordea Bank Abp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABP-671 in Hyperuricemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABP-671 in Hyperuricemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABP-671 in Hyperuricemia Drug Details: ABP-671 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABP-450 in Migraine
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ABP-450 in Migraine Drug Details: ABP-450 is under development for the treatment of cervical dystonia...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABP-450 in Spasmodic Torticollis (Cervical Dystonia)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ABP-450 in Spasmodic Torticollis (Cervical Dystonia) Drug Details: ABP-450 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATI-2138 in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATI-2138 in Ulcerative Colitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATI-2138 in Ulcerative Colitis Drug Details: ATI-2138 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Irinotecan Hydrochloride in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Irinotecan Hydrochloride in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Irinotecan Hydrochloride in Epithelial Ovarian Cancer Drug Details: Irinotecan...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Niraparib in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Niraparib in Metastatic Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Niraparib in Metastatic Melanoma Drug Details: Niraparib (MK-4827, Zejula) is an...